Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients

Xinyi Peng1, Miaomiao Zhuang1, Qirui Song1

  • 1Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beilishi Rd. 167, Xicheng District, Beijing 100037, China.

Insights

Controlling more cardiovascular risk factors in hypertensive patients significantly lowers their risk of cardiovascular events and death. Comprehensive risk factor management is crucial for reducing cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Preventive Medicine

Background:

  • The impact of baseline risk factor control on cardiovascular outcomes in hypertensive patients undergoing blood pressure interventions remains unclear.
  • The association between baseline risk factor control and cardiovascular outcomes in hypertensive patients using blood pressure-lowering strategies needs further investigation.

Purpose of the Study:

  • To investigate the relationship between the level of baseline risk factor control and cardiovascular outcomes in hypertensive patients.
  • To determine if baseline risk factor control is associated with cardiovascular outcomes in hypertensive patients receiving blood pressure-lowering therapy.

Main Methods:

  • Analysis of data from the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial.
  • Exclusion of participants lacking complete baseline risk factor data.
  • Utilized Cox proportional hazard models to assess the association between risk factor control levels (≥6, 5, 4, ≤3) and cardiovascular outcomes (composite of cardiovascular events and all-cause mortality).

Main Results:

  • Analysis included 8337 participants with a median follow-up of 3.19 years.
  • Each additional uncontrolled risk factor increased cardiovascular risk by 24% (HR 1.24, 95% CI 1.11-1.37).
  • Patients with ≤3 controlled risk factors had a 95% higher cardiovascular risk compared to those with optimal control (HR 1.95, 95% CI 1.37-2.77).

Conclusions:

  • A clear, stepwise association exists between cardiovascular risk and the number of controlled risk factors in hypertensive patients.
  • Intensified modification of multiple risk factors reduces cardiovascular risk, independent of antihypertensive treatment intensity.
  • Comprehensive risk factor control strategies are essential for mitigating cardiovascular disease risk in hypertensive individuals.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
627
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
1.1K